abrdn Healthcare Investors
104 hedge funds and large institutions have $150M invested in abrdn Healthcare Investors in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 10 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 20
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
3% more funds holding
Funds holding: 101 → 104 (+3)
0.77% less ownership
Funds ownership: 18.13% → 17.36% (-0.77%)
11% less capital invested
Capital invested by funds: $168M → $150M (-$18.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.5M |
| 2 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
+$948K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$774K |
| 4 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$485K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$460K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.1M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.64M |
| 3 |
SFS
Shaker Financial Services
Arlington,
Virginia
|
-$602K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$568K |
| 5 |
Mercer Global Advisors
Denver,
Colorado
|
-$494K |
HQH Hedge Fund Activity: Q2 2022 in Review
104 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in abrdn Healthcare Investors (HQH) for Q2 2022, worth a combined $150M — down 11% from $168M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new HQH positions and 10 closed out — a net gain of 3 holders — while 48 added to existing stakes and 20 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.5M. The largest seller was Wolverine Asset Management, cutting an estimated $2.1M.
- 104 institutional investors held abrdn Healthcare Investors (HQH) as of Q2 2022, up from 101 in Q1 2022.
- Funds reported $150M of abrdn Healthcare Investors stock for Q2 2022, down 11% quarter-over-quarter.
- 13 funds opened new abrdn Healthcare Investors positions in Q2 2022 and 10 closed out, a net change of +3 holders.
- The largest abrdn Healthcare Investors buyer in Q2 2022 was Morgan Stanley, an estimated $1.5M added.
- The largest abrdn Healthcare Investors seller in Q2 2022 was Wolverine Asset Management, an estimated $2.1M sold.
Based on aggregated 13F filings for Q2 2022.